BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25417682)

  • 1. Successful treatment of a large cutaneous ulcer and improvement in the hematologic manifestations of felty syndrome with rituximab.
    Ayzenberg M; Shenberger KN
    J Clin Rheumatol; 2014 Dec; 20(8):440-1. PubMed ID: 25417682
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical effectiveness of filgrastim in beta-thalassaemia leg ulcer.
    Stavrianeas N; Xifteri A; Kavatha D; Vrettou H
    Dermatology; 2005; 211(2):173;author reply 173. PubMed ID: 16088173
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose tissue plasminogen activator for calciphylaxis.
    Sewell LD; Weenig RH; Davis MD; McEvoy MT; Pittelkow MR
    Arch Dermatol; 2004 Sep; 140(9):1045-8. PubMed ID: 15381542
    [No Abstract]   [Full Text] [Related]  

  • 4. A beneficial long-term and consistent response to rituximab in the treatment of refractory neutropenia and arthritis in a patient with Felty syndrome.
    Sarp U; Ataman S
    J Clin Rheumatol; 2014 Oct; 20(7):398. PubMed ID: 25275774
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rituximab for treatment of Felty’s syndrome].
    Becker H; Appel H; Fassbinder T; Heitzmann D; Willeke P; Jacobi AM
    Z Rheumatol; 2014 Jun; 73(5):465-6, 468. PubMed ID: 24659095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers.
    Méry L; Girot R; Aractingi S
    Dermatology; 2004; 208(2):135-7. PubMed ID: 15057003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Felty's Syndrome Associated with Skin Ulcers and Extranodal NK/T-cell Lymphoma.
    Shu E; Kanoh H; Kito Y; Seishima M
    Acta Derm Venereol; 2015 Jul; 95(6):754-5. PubMed ID: 25673081
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of rheumatoid arthritis with Felty syndrome complicated by late-onset ankylosing spondylitis and psoriatic arthritis: a potpourri of rheumatic diseases.
    Godhwani S; Gruber BL; Finzel K
    J Clin Rheumatol; 2015 Jan; 21(1):53-5. PubMed ID: 25539441
    [No Abstract]   [Full Text] [Related]  

  • 9. Bosentan: a novel therapy for leg ulcers in Werner syndrome.
    Noda S; Asano Y; Masuda S; Miyagawa T; Sugita M; Yamamoto M; Kogure A; Tamaki Z; Mitsui H; Hoashi T; Sugaya M; Sato S
    J Am Acad Dermatol; 2011 Aug; 65(2):e54-e55. PubMed ID: 21763553
    [No Abstract]   [Full Text] [Related]  

  • 10. "Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections".
    Pukšić S; Mitrović J; Morović-Vergles J
    J Clin Rheumatol; 2017 Jan; 23(1):70-71. PubMed ID: 28002164
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose pulse methylprednisolone is an effective therapy for severe SLE flares.
    Kong KO; Badsha H; Lian TY; Edwards CJ; Chng HH
    Lupus; 2004; 13(3):212-3. PubMed ID: 15119552
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa.
    Kawakami T; Soma Y
    J Am Acad Dermatol; 2010 Oct; 63(4):602-6. PubMed ID: 20675014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felty's syndrome with hyperthyroidism: a case report and literature review.
    Huang T; Liu M; Xu G
    Int J Rheum Dis; 2014 Jan; 17(1):122-4. PubMed ID: 24472276
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonhealing Leg Ulcer in a Middle-aged Indian Man.
    Vinay K; De D; Saikia UN
    JAMA Dermatol; 2018 Feb; 154(2):207-208. PubMed ID: 28973107
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of a chronic venous leg ulcer using a topical beta-blocker.
    Lev-Tov H; Dahle S; Moss J; Isseroff RR
    J Am Acad Dermatol; 2013 Oct; 69(4):e204-5. PubMed ID: 24034405
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of refractory neutropenia in Felty's syndrome with rituximab.
    Wang CR; Chiu YC; Chen YC
    Scand J Rheumatol; 2018 Jul; 47(4):340-341. PubMed ID: 28753121
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy-resistant leg ulcer caused by multiple myeloma.
    Bago A; Schweiter J; Kiss M; Furesz J; Vajda A; Balo-Banga JM
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):647-8. PubMed ID: 16164734
    [No Abstract]   [Full Text] [Related]  

  • 18. The Treatment of Low Leg Nonischemic Ulcers With a Traditional Chinese-Pharmaceutical Medium: A Randomized Controlled Multicenter Clinical Study.
    Zhang J; Chen X; Yu L; Xue J; Zhu Z; Wang C; Tang T; Feng Z; Yao C
    Int J Low Extrem Wounds; 2019 Jun; 18(2):186-191. PubMed ID: 31111752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic leg ulcers with topical activated protein C.
    Whitmont K; Reid I; Tritton S; March L; Xue M; Lee M; Fulcher G; Sambrook P; Slobedman E; Cooper A; Jackson C
    Arch Dermatol; 2008 Nov; 144(11):1479-83. PubMed ID: 19015423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of rituximab in Felty's syndrome.
    Shipley E; Héraud A; Hennette A; Vernhes JP
    Joint Bone Spine; 2008 Oct; 75(5):621-2. PubMed ID: 18805034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.